Pregnancy
Conditions
Brief summary
To assess the proportion of women who use HERC for ≥2 years of duration
Interventions
Levonorgestrel-releasing intrauterine device 20 mcg/day
DRUGParaGard
Copper T380A
DRUGImplanon/Nexplanon
Etonorgestrel contraceptive implant
Sponsors
University of Utah
Bayer
Study design
Observational model
COHORT
Time perspective
RETROSPECTIVE
Eligibility
Sex/Gender
FEMALE
Age
15 Years to 44 Years
Healthy volunteers
No
Inclusion criteria
-Women who had an IUD or contraceptive implant inserted and removed within the University of Utah from January 1, 2004 to October 31, 2012
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Proportion of women who use HERC | 2 years post-HERC initiation |
Secondary
| Measure | Time frame |
|---|---|
| Duration of real world use of three different HERC devices | 2 years post-HERC initiation |
Other
| Measure | Time frame |
|---|---|
| Difference in patient characteristics of women who chose different HERC devices | 2 years post-HERC initiation |
| Proportion of HERC used for ≥3 years of duration | ≥3 years post-HERC initiation |
| Model the predictors of ≥3 years of duration | ≥3 years post-HERC initiation |
Countries
United States
Outcome results
None listed